破壞性行為障礙治療市場 – 2024 年至 2029 年預測

預計破壞性行為障礙治療市場在預測期內將以 5.82% 的複合年成長率成長。

破壞性行為障礙是一組具有頻繁煩躁、粗魯、言語不守規矩和攻擊性行為等症狀的疾病，可能會損害社交、家庭和個人功能。這些包括品行障礙、對立障礙和間歇性爆發性障礙。有多種治療方法可以治療這種病理，包括家庭治療、團體治療以及提高患者社交和情緒技能的培訓。

破壞性行為障礙治療市場的推動要素

影響破壞性行為障礙治療市場成長的主要因素是破壞性行為障礙治療的進步以及對心理健康問題早期診斷的認知的提高。新興市場的巨大潛力，包括改善的醫療基礎設施和不斷增加的未滿足的醫療需求，也正在推動破壞性行為障礙治療產業的發展。此外，由於政府投資增加、對增強醫療服務的需求增加以及醫療旅遊的興起，新興國家的醫療保健產業正在不斷發展。

破壞性行為障礙的盛行率

破壞性行為障礙是一種影響兒童並導致他們對他人表現出攻擊性、不合作和挑釁行為的障礙。破壞性行為障礙盛行率的增加、更快的反應和周轉時間、更好的診斷、非侵入性治療程序、電腦支援的可用性以及對大量診斷產品的依賴正在增加破壞性行為障礙的盛行率。殘疾治療市場。根據美國兒童與青少年精神醫學會的數據，對立障礙影響 1% 至 16% 的青少年和學齡兒童。這種疾病在男性中比在女性中更常見。

對兒童心理健康措施的需求不斷成長

各種非政府組織的參與不斷增加以及對破壞性行為障礙治療的認知不斷提高，正在推動破壞性行為障礙治療市場的成長。例如，啟動了調查計畫，旨在培訓家長治療兒童破壞性行為障礙並預防對立對立障礙 (ODD)。此外，人工智慧（AI）與兒科崩壞疾病治療的結合正在創造進一步的成長機會。這使得孩子們能夠在相關醫生的持續指導下應對壓力情況。

藥物管理越來越受歡迎

藥物用於治療對立和行為障礙。對於這些情況，需要使用各種合成藥物和草藥來為大腦和神經提供適當的刺激。小組會議、教養方式調整和情緒技能訓練等治療在早期階段更為有益，因此在後期階段才考慮使用這些藥物。這些因素影響預測期內治療的成長，並有助於破壞性行為障礙治療市場的成長。此外，在許多情況下，由於患者不了解自己的症狀，導致治療延誤並需要藥物管理。

以客戶為中心的治療越來越受歡迎

以客戶為中心的治療方法透過關注病人來改變破壞性行為障礙的外在症狀。目的是鼓勵該人以更適當的方式行事。在以客戶為中心的治療中，患者與治療師進行一對一或小組互動，以培養必要的技能。放鬆技巧和憤怒管理技巧只是以客戶為中心的治療中教授的應對策略的幾個例子。

在北美，破壞性行為障礙治療市場預計將穩定成長。

由於兒童和成人行為障礙的盛行率不斷增加，預計北美的破壞性行為障礙治療產業將在預測期內成長。隨著人們越來越意識到其症狀，破壞性行為障礙治療市場預計將在該地區成長。例如，猶他州的高地嶺醫院舉辦家長教育課程，向家長介紹破壞性行為障礙治療的早期症狀。這些舉措預計將有助於該地區的市場成長。此外，由於目標人口不斷成長以及成年人藥物濫用現像日益普遍，亞太地區被認為是破壞性行為障礙治療產業成長第二快的地區。

破壞性行為障礙治療計劃

• 家長計畫：該計劃幫助父母在孩子尋求幫助或關注時做出適當的反應。
• 兒童計畫：該計畫幫助孩子對家人和自己感到更加樂觀，提高他們的人際互動、溝通和分析能力，幫助他們更好地管理憤怒和情緒溝通。
• 青少年計畫：此計畫鼓勵父母花更多時間陪伴青少年。
• 教師計畫：該計畫培訓教師控制學生在課堂上的行為。透過提高孩子的情感和社交智力並與他們一起工作，讓父母參與其中。

破壞性行為障礙治療藥物

• 興奮劑，FDA 已批准興奮劑用於治療過動症。
• 非刺激性 ADHD 藥物，FDA 已批准使用胍法辛 ER (Intuniv®) 和托莫西汀 (Strattera®) 治療 ADHD。
• 抗驚厥藥物 FDA 已核准抗驚厥藥物雙丙戊酸鈉（Depakene®、Depakote®、Depakote ER®）用於治療癲癇發作。
• 抗精神病藥物：FDA 已核准抗精神病藥物用於治療精神病（一種精神疾病）。

目錄

第1章簡介

• 市場概況
• 市場定義
• 調查範圍
• 市場區隔
• 貨幣
• 先決條件
• 基準年和預測年時間表

第2章調查方法

• 調查資料
• 先決條件

第3章執行摘要

• 研究亮點

第4章市場動態

• 市場促進因素
• 市場限制因素
• 波特五力分析
• 產業價值鏈分析

第5章破壞性行為障礙治療市場：依類型

• 介紹
• 破壞性行為障礙
• 品行障礙
• 間歇性爆發性障礙

第6章破壞性行為障礙治療市場：依治療分類

• 介紹
• 用藥管理
• 綜合評價
• 育兒療法
• 團體治療
• 個別治療

第7章破壞性行為障礙治療市場：依最終使用者分類

• 介紹
• 醫院
• 診所
• 其他

第8章破壞性行為障礙治療市場：按地區

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章競爭環境及分析

• 主要企業及策略分析
• 市場佔有率分析
• 合併、收購、協議和合作
• 供應商競爭力矩陣

第10章 公司簡介

• Valley Behavioural Health
• Piney Ridge Treatment Center
• The Recovery Village
• Highland Ridge Hospital
• Sierra Tucson
• Behavioural Neurotherpay Clinic
• Cross Creek Hospital
• Mayo Clinic
• Mind Plus
• Kennedy Krieger Institute

The disruptive behavior disorder treatment market is estimated to grow at a CAGR of 5.82% during the forecast period.

Disruptive behaviour disorders are a group of disorders with symptoms like frequent temper, rudeness, speaking harshly, and aggressive behavior which can impair social, familial, and personal functioning. These include conduct disorder, defiant disorder, and intermittent explosive disorder. To treat this condition there are various therapies available including family therapy, group therapy, and training which are given to patients to improve their social and emotional skills.

Driving factors for the disruptive behavior disorder treatment market

The major factor influencing the growth of the disruptive behavior disorder treatment market is the advancement in disruptive behavior disorder treatment in addition to raising awareness related to early diagnosis of mental health issues. The high potential in emerging markets with the improvement in healthcare infrastructure, and increase in unmet medical needs is also driving the disruptive behavior disorder treatment industry. Moreover, the healthcare industry in emerging countries is developing owing to the growing investment by the government of various nations, the increase in demand for enhanced healthcare services, and the rising medical tourism.

Growing prevalence of oppositional defiant disorder

Oppositional defiant disorder is a condition that affects children, and they behave in an aggressive, uncooperative, and defiant manner with others. The increasing prevalence of the oppositional defiant disorder, faster response and turnaround time, better diagnosis, non-invasive treatment procedures, availability of computational support, and reliance on the substantial number of diagnostic products are fueling the disruptive behavior disorder treatment market growth. According to the American Academy of Child & Adolescent Psychiatry, oppositional defiant disorder affects 1% to 16% of adolescents and school-aged children. Males are more likely to have the condition diagnosed than females.

Rising need to address children's mental health

The growing involvement of various NGOs and rising awareness of disruptive behaviour disorder treatment are fueling the disruptive behavior disorder treatment market growth. For instance, a research program named Strongest Families Finland Canada (SFFC) Smart Website was launched to train parents about disruptive behaviour disorder among children to prevent Oppositional Defiant Disorder (ODD). Furthermore, the integration of disruptive disorder treatment for children with Artificial Intelligence (AI) is creating more growth opportunities. This will help children cope with stressful situations with continuous guidance from concerned doctors.

Medication management is gaining popularity

Medication management is used for treating oppositional defiant and conduct disorders. In these conditions, various synthetic and herbal drugs are prescribed for proper brain and nervous stimulation. These medications are considered in the later stages as therapies are more beneficial in the primary stage, such as group sessions, parenting modifications, and emotional skills training. These factors are influencing the growth of therapies during the forecast period which contributes to disruptive behavior disorder treatment market growth. Furthermore, there are multiple cases where the patient is unaware of the symptoms and there are delays in treatment which leads to the use of medication management.

Increasing popularity of client-focused treatments

Client-focused therapies alter the outward manifestations of a disruptive behavior disorder by focusing on the patient with the disease. The intention is to encourage the person to act in more suitable ways. In client-focused therapies, the patient interacts with a therapist one-on-one or in a group setting to acquire the necessary skills. Relaxation techniques and anger management techniques are only a couple of the coping mechanisms that may be taught in client-centred therapies.

In North America, it is projected that the disruptive behavior disorder treatment market will grow steadily.

The disruptive behaviour disorder treatment industry is anticipated to grow in North America during the projected period due to the increasing prevalence of behavioural disorders among children and adults. As people become more aware of the symptoms the disruptive behavior disorder treatment market is anticipated to grow in the region. For instance, learning sessions for parents to impart knowledge of early symptoms of disruptive behavior disorder are being conducted by the Highland Ridge Hospital of Utah. Such initiatives are predicted to contribute to the growth of the market in the region. Additionally, Asia Pacific is considered to be the second largest growing disruptive behavior disorder treatment industry owing to the increasing target population and growing substance abuse among adults.

Disruptive behavior disorder treatment programs

• Parent Programs, this program encourages parents to respond in a good manner when their youngster requests assistance or attention. Set attainable objectives for the child and better keep an eye on the child's actions.
• Child Programs, program help children feel more optimistic about their family and themselves enhancing their interpersonal, communicative, and analytical abilities to better manage anger and emotional communication
• Teen Programs, this program influences parents to spend extra time with their teens. Clearly define the rules and the penalties for breaching them.
• Teacher Programs, this program trains teachers to control student behavior in the classroom. Boost the emotional and social intelligence of kids and keep the parents involved by working with them.

Disruptive behavior disorder treatment medicines

• Stimulants, For the treatment of ADHD, the FDA has authorised stimulants. They are also used by certain medical practitioners to treat DBDs.
• Nonstimulant ADHD medicines, The FDA has authorised the use of guanfacine ER (Intuniv®) and atomoxetine (Strattera®) to treat ADHD.
• Anticonvulsant medicine, The FDA has given the anticonvulsant drug divalproex (Depakene®, Depakote®, and Depakote ER®) approval to treat seizures.
• Antipsychotics, The FDA has given the drug antipsychotics approval to treat psychosis, a kind of mental disease.

Market Key Developments

• In October 2022, The Anna Freud Centre's thorough analysis of worldwide research demonstrated the beneficial effects of treatments on young children and their careers.
• In October 2022, Lupin announced the release of Paliperidone Extended-Release Tablets, a generic version of Janssen Research and Development's Invega Extended-Release Tablets.
• In January 2022, Bionomics began the mid-stage BNC210 study to treat social anxiety disorder.

Segmentation:

By Type

• Oppositional Defiant Disorder
• Conduct Disorder
• Intermittent Explosive Disorder

By Treatment

• Medication Management
• Comprehensive Evaluation
• Parenting Therapy
• Group Therapy
• Individual Therapy

By End-User

• Hospitals
• Clinics
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY TYPE

• 5.1. Introduction
• 5.2. Oppositional Defiant Disorder
• 5.3. Conduct Disorder
• 5.4. Intermittent Explosive Disorder

6. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY TREATMENT

• 6.1. Introduction
• 6.2. Medication Management
• 6.3. Comprehensive Evaluation
• 6.4. Parenting Therapy
• 6.5. Group Therapy
• 6.6. Individual Therapy

7. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Clinics
• 7.4. Others

8. DISRUPTIVE BEHAVIOR DISORDER TREATMENT MARKET, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Valley Behavioural Health
• 10.2. Piney Ridge Treatment Center
• 10.3. The Recovery Village
• 10.4. Highland Ridge Hospital
• 10.5. Sierra Tucson
• 10.6. Behavioural Neurotherpay Clinic
• 10.7. Cross Creek Hospital
• 10.8. Mayo Clinic
• 10.9. Mind Plus
• 10.10. Kennedy Krieger Institute